Abstract
Cholera outbreaks remain an important public health challenge in Kenya, especially in areas with poor sanitation and hygiene including urban informal settlements, refugee camps and rural areas bordering large water bodies. Even in endemic settings, the distribution of cases exhibits spatial and temporal variations. Utilizing a Poisson discrete space-time scan statistic (SaTScan), this study investigated the temporal trends and the nature of spatial spread of cholera within selected high-risk areas in Kenya. The study was conducted in an urban informal settlement in Nairobi (Mukuru), a refugee camp in Northern Kenya (Dadaab) and the four counties bordering Lake Victoria region. Retrospective cholera line list data from January 2012 to December 2022 in the selected high-risk areas was used. SaTScan v10.1.2 was used to carry out Spatiotemporal analysis and generate spatial clusters. Throughout the study period, a total of 7,372 cholera cases were reported, corresponding to a lower annual incidence rate of 12.2 per 100,000 people compared to a mean annual incidence of 25 cases per 100,000 population previously reported in Kenya. The highest number of cases (n=5934) were reported between 2015 and 2018 with an annual incidence rate of 27.0 per 100,000 people, indicating a relative risk (RR) of 7.22 and a log-likelihood ratio (LLR) of 3015.17 (p< 0.001). The risky clusters (RR>1) were in Dadaab, Fafi, Suna West, Nyatike, Ugunja, Ndhiwa and Suna East sub counties with annual cases of 111.6, 164.1, 28.4, 19.9, 19.4, 14.0 and 13.9 per 100,000, respectively. The sub-counties of Nyakach, Nyando, Rachuonyo East, Kisumu East and Kisumu Central were reported as low-risk clusters, with a relative risk of 0.055 and an annual incidence rate of 1.1 cases per 100,000 individuals. Out of the thirty-two sub-counties included in the study, ten of them did not report any cases of cholera during the study period. Cholera cases waxed every three years in the selected high-risk areas. This data on hotspots specific to endemic settings forms a basis for prompt public health response and resource allocation by prioritizing the significantly high-risk clusters to control and eventually eliminate the disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by Kenyatta National Hospital_University of Nairobi Ethical Research Committee (KNH_UoN ERC) under approval number P731/09/2021
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its supporting information files
